Marc S. Ayers
Amministratore Delegato presso Romark, L.C.
Profilo
Marc S.
Ayers founded Romark, L.C.
in 1994, where he is working as President & Chief Executive Officer from 1994.
Mr. Ayers also currently works at Romark Global Pharma LLC, as Director and Romark SCS, as Director.
Mr. Ayers received his graduate degree in 1981 from The University of Alabama.
Posizioni attive di Marc S. Ayers
| Società | Posizione | Inizio |
|---|---|---|
Romark, L.C.
 Romark, L.C. Pharmaceuticals: MajorHealth Technology Romark LC is a pharmaceutical company, which engages in the development and commercialization of innovative small molecules for treating infectious diseases and cancers. It markets Alinia for Oral Suspension, a drug used for the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 12 months of age and older. The company was founded by Jean-François Rossignol and Marc S. Ayers in 1993 and is headquartered in Tampa, FL. | Amministratore Delegato | 01/01/1994 |
Romark Global Pharma LLC
 Romark Global Pharma LLC Pharmaceuticals: MajorHealth Technology Romark Global Pharma LLC engages in the operation of an integrated biopharmaceutical company. The firm specializes in the discovery, development, and commercialization of small molecules for treating infectious diseases and cancers. The company was founded on November 14, 2014 and is headquartered in San Juan, Puerto Rico. | Direttore/Membro del Consiglio | - |
Romark SCS
 Romark SCS Pharmaceuticals: MajorHealth Technology Romark SCS operates as pharmaceutical company. The company is headquartered in Luxembourg. | Direttore/Membro del Consiglio | - |
Formazione di Marc S. Ayers
| The University of Alabama | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Romark, L.C.
Romark, L.C. Pharmaceuticals: MajorHealth Technology Romark LC is a pharmaceutical company, which engages in the development and commercialization of innovative small molecules for treating infectious diseases and cancers. It markets Alinia for Oral Suspension, a drug used for the treatment of diarrhea caused by Giardia lamblia or Cryptosporidium parvum in patients 12 months of age and older. The company was founded by Jean-François Rossignol and Marc S. Ayers in 1993 and is headquartered in Tampa, FL. | Health Technology |
Romark Global Pharma LLC
Romark Global Pharma LLC Pharmaceuticals: MajorHealth Technology Romark Global Pharma LLC engages in the operation of an integrated biopharmaceutical company. The firm specializes in the discovery, development, and commercialization of small molecules for treating infectious diseases and cancers. The company was founded on November 14, 2014 and is headquartered in San Juan, Puerto Rico. | Health Technology |
Romark SCS
Romark SCS Pharmaceuticals: MajorHealth Technology Romark SCS operates as pharmaceutical company. The company is headquartered in Luxembourg. | Health Technology |
- Borsa valori
- Insiders
- Marc S. Ayers